ALB · Albemarle Corporation — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on ALB. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About ALB · Albemarle Corporation
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Live Quote
HOLD (score -1) · 12-1 mom 182.3% · RSI 36.1 · above_200_only · -30.4% from high
Targets blend Wall Street consensus (22 analysts: low $83.28 / mean $214.65 / high $264.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Stage crashed before producing an artifact (e.g. LM Studio timeout, malformed JSON, network error). The cooldown will hold this off the queue for ~1h before retry.
Material insider selling ($3M) outweighs purchases, options flow is heavily bearish, and technicals are weak (RSI 30, below 50DMA). Unverified anti-signals (dilution/accounting) and lack of a concrete valuation or catalyst edge justify skipping.
Albemarle is the world's largest lithium producer, also operating bromine and catalyst businesses. The Q1 2026 EPS beat ($2.95 actual vs $1.31 estimate = +124.6% surprise) marked a dramatic reversal from three consecutive quarters of misses. Forward P/E of ~12.9x looks reasonable for a cyclical lithium name with improving fundamentals, but EV/EBITDA of 21.5x and ROIC near zero (TTM net loss) reflect ongoing margin stress. The stock has sold off ~30% from its April 16, 2026 52-week high of $215.62 to $155.44 on June 5, following a massive Q1 beat that may have triggered profit-taking. CEO Masters sold ~16,400 shares (code S = open-market sale) in February and May 2026 for diversification — no open-market insider purchases detected in the past 90 days. The CAO retirement announcement on April 13 with a June 1 effective date is a management continuity flag but was pre-announced without dispute. Options flow shows heavy put volume bias (bearish directional, net notional $113K puts vs zero calls at near-term expiry). IV is elevated in the 55-66% range across tenors. Lithium spot price recovery remains the primary catalyst; next earnings are July 29, 2026.
Score of 23 falls well below the publish threshold. The stock has run +156% YTD with zero insider buying, no material mispricing at ~21x forward P/E, and faces active anti-signal gates for dilution ($2.3B mandatory convertibles) and customer concentration. While IV is elevated, the fundamental catalyst and quality metrics do not support a publishable thesis or justify overriding the gates.
Albemarle reported Q1 2026 EPS of $2.95 vs. $1.31 consensus estimate — a +139% beat driven by ~70% Energy Storage segment revenue growth on recovering lithium prices and volumes, alongside $40M in year-to-date cost improvements toward their full-year $100-150M productivity target. The stock has run +156% over the past year off the late-2025 lows and sits just 8% below its $221 high (set May 7). However, at 20.76x forward P/E and 25.7x EV/EBITDA with gross margins that remain well below historical peak levels, there is no clear mispricing relative to intrinsic value for a commodity-chemicals name still recovering from multi-year lithium destocking. No open-market insider purchases were found in the trailing window; management compensation came through equity grants rather than personal stock buys. The technical setup is constructive but extended near-term: above both 50- and 200-DMAs, RSI neutral at 59.3, with a bearish MACD cross 8 bars ago suggesting short-term consolidation before further upside. IV is elevated (65-69% ATM) making the current environment ideal for premium-selling strategies rather than directional long positions.